Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008640	s-bopeabg	titre (—)	55	61	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma

3.50

3.56

1.2

1.0

—

Asthma, excluding more controls

3.48

3.53

1.2

1.0

—

Dorsalgia

3.21

3.44

1.1

1.2

—

Asthma, including avohilmo

2.73

3.26

1.2

1.1

—

Migraine

3.60

3.16

1.0

1.1

—

Asthma (mode)

3.31

3.12

1.2

1.0

—

Adenomyosis (Endometriosis of uterus)

7.51

3.05

1.0

—

Tramadol

3.51

2.94

1.1

1.2

—

Asthma (only as main-diagnosis)

3.31

2.75

1.2

1.0

—

Depression or dysthymia

3.57

2.73

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

3.27

2.71

1.2

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

4.08

2.67

1.2

1.1

—

Pain (limb, back, neck, head abdominally)

3.85

2.65

1.0

1.2

—

Other intervertebral disc disorders

3.14

2.63

1.1

—

Other dorsopathies, not elsewhere classified

2.71

2.49

1.1

—

Chronic lower respiratory diseases

2.38

2.41

1.2

1.1

—

Other obstetric conditions, not elsewhere classified

3.58

2.39

1.2

1.1

—

Sleep disorders

2.61

2.37

1.1

—

Other benign neoplasms of skin

4.12

2.36

1.1

1.0

—

Other bacterial diseases

2.57

2.27

1.1

—

Injury, poisoning and certain other consequences of external causes

3.47

2.22

1.0

1.2

—

Other disorders of patella

5.56

2.21

1.2

1.0

—

Non-invasive ventilation

5.58

2.18

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

2.52

2.16

1.2

1.1

—

Endometriosis

3.61

2.16

1.1

—

Lower back pain or/and sciatica

2.41

2.15

1.0

1.2

—

Insomnia

2.50

2.04

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.27

1.98

1.1

—

Recurrent or chronic depression

3.52

1.96

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

2.76

1.94

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

3.02

1.94

1.1

1.0

—

Disorders of eyelid, lacrimal system and orbit

2.40

1.91

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.37

1.90

1.2

1.1

—

Disorders of other endocrine glands

2.91

1.89

1.1

1.0

—

Opioids

2.49

1.87

1.0

1.2

—

Benign neoplasms

2.45

1.84

1.0

1.1

—

Blepharochalasis

4.17

1.82

1.0

1.1

—

Other bacterial diseases

2.29

1.82

1.2

1.1

—

Dorsopathies

2.36

1.82

1.0

1.1

—

Pain in limb

2.36

1.81

1.0

1.1

—

Falls/tendency to fall

2.26

1.79

1.1

—

Oral corticosteroids

2.19

1.75

1.1

—

Injuries to the knee and lower leg

2.13

1.74

1.0

1.2

—

Other disorders of eyelid

3.36

1.74

1.0

1.1

—

Dental operations

3.27

1.74

1.0

1.1

—

Cough

2.88

1.68

1.0

1.2

—

Migraine with aura

3.16

1.66

1.0

1.1

—

Persons encountering health services in other circumstances

2.79

1.64

1.1

1.0

—

Sciatica+with lumbago

2.80

1.63

1.0

1.1

—

Accidents

2.40

1.59

1.0

1.1

—

Intracranial trauma

2.56

1.57

1.1

—

Other septicaemia

3.43

1.55

1.4

1.0

—

Neoplasms

2.33

1.54

1.0

1.1

—

Asthma/COPD (KELA code 203)

2.16

1.53

1.3

1.1

—

Cervicobrachial syndrome

3.33

1.52

1.2

1.1

—

Low back pain

2.58

1.52

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

2.19

1.50

1.1

—

Cholelithiasis

2.23

1.50

1.1

—

Bacterial infection, other or unspecified

2.89

1.50

1.0

1.1

—

Allergic asthma (mode)

3.26

1.49

1.2

1.1

—

Allergic asthma (mode), excluding more controls

3.26

1.49

1.2

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.82

1.48

1.0

1.1

—

Pain in joint

2.94

1.46

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.58

1.44

1.0

1.1

—

Personality disorders, excluding more controls

3.12

1.43

1.0

—

Cholelithiasis, broad definition with cholecystitis

2.18

1.42

1.1

—

Examination and observation for other reasons

2.37

1.42

1.0

1.1

—

Disorders of lens

0.00

1.38

0.0

1.0

—

Acute upper respiratory infections

2.00

1.36

1.0

1.1

—

Migraine with aura and triptan purchases

2.94

1.36

1.0

—

Benign neoplasm: Colon

2.60

1.35

1.2

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.04

1.35

1.0

1.1

—

Fall on same level

1.96

1.35

1.1

—

Other diseases of hard tissues of teeth

2.82

1.35

1.0

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

2.23

1.35

1.1

—

Diseases of oral cavity, salivary glands and jaws

2.81

1.34

1.0

1.2

—

Septicaemia

2.92

1.34

1.4

1.0

—

Codeine

2.26

1.34

1.0

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

2.15

1.33

1.2

1.1

—

Diseases of arteries, arterioles and capillaries

2.61

1.32

1.2

1.0

—

Triptan medication for migraine, min. 3 purchases

2.15

1.31

1.0

1.2

—

Artificial joint operation, meniscal resection

2.16

1.31

1.0

1.1

—

Bacterial infection, other or unspecified

2.54

1.30

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.21

1.30

1.0

—

Codeine or tramadol medication

1.98

1.29

1.0

1.2

—

External causes of morbidity and mortality

2.36

1.26

1.0

1.1

—

Certain infectious and parasitic diseases

2.36

1.26

1.0

1.1

—

Meniscus derangement

2.53

1.26

1.2

1.1

—

Transport accidents

2.46

1.25

1.0

1.1

—

Other external causes of accidental injury

2.18

1.21

1.0

1.1

—

Personality disorders

2.63

1.21

1.0

1.1

—

Gingivitis and periodontal diseases

2.00

1.21

1.0

1.1

—

Senile cataract

0.00

1.20

0.0

1.0

—

Carpal tunnel syndrome

2.14

1.19

1.3

1.1

—

ILD medications

1.90

1.18

1.1

—

Unspecified fall

2.27

1.16

1.2

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.95

1.13

1.1

—

Spondylopathies

2.08

1.13

1.1

—

Mood [affective] disorders

1.90

1.13

1.2

1.1

—

Mood disorders

1.89

1.12

1.2

1.1

—

1.87

1.11

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.00

1.11

1.0

1.1

—

Headache

2.00

1.10

1.1

—

Papulosquamous disorders

2.38

1.09

1.6

1.0

—

Cerebrovascular diseases

2.24

1.08

1.1

1.0

—

Injuries to the hip and thigh

2.38

1.08

1.2

1.0

—

Autoimmune diseases related-to ILD

1.94

1.06

1.3

1.1

—

Inflammatory bowel disease treatment related agents

1.82

1.06

1.0

1.1

—

Explicit Sepsis

2.33

1.06

1.4

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.86

1.04

1.0

1.1

—

Unspecified mental disorder

2.27

1.03

1.0

—

Ischaemic Stroke, excluding all haemorrhages

2.33

1.03

1.2

1.0

—

First line medication for Crohn's disease

1.85

1.02

1.1

—

Other soft tissue disorders, not elsewhere classified

1.90

1.02

1.0

1.1

—

Pure hypercholesterolaemia

2.08

1.01

1.1

—

Diseases of pulp and periapical tissues and dental caries

2.11

1.01

1.0

1.1

—

Finngen Rheumatological endpoints

1.90

1.01

1.0

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1.87

1.00

1.1

—

Presence of other functional implants

0.00

1.00

0.0

1.1

—

Stroke, excluding SAH

2.28

1.00

1.2

1.0

—

Other retinal disorders

0.00

0.99

0.0

1.1

—

Bronchitis

1.80

0.98

1.1

—

Disorders of vitreous body and globe

0.00

0.97

0.0

1.1

—

Polyarthropathies

1.99

0.97

1.1

—

Other neurological diseases

1.96

0.97

1.1

—

Concussion

2.23

0.93

1.2

1.1

—

Fracture of forearm

1.89

0.93

1.0

1.1

—

Conjunctivitis

1.75

0.92

1.1

—

Asthma, unspecified (mode)

2.15

0.91

1.0

—

Asthma, unspecified (mode), excluding more controls

2.14

0.91

1.0

—

Cardiovascular diseases

1.95

0.90

1.0

1.1

—

Other pulmonary diagnosis

1.91

0.88

1.0

—

Excluding asthma or asthma-COPD overlap

1.91

0.88

1.0

—

COPD differential diagnosis

1.91

0.88

1.0

—

ILD differential diagnosis

1.91

0.88

1.0

—

Fever of other and unknown origin

2.05

0.88

1.0

1.2

—

Sleep disorders (combined)

1.75

0.88

1.1

—

Cholecystectomy

1.86

0.87

1.1

—

Nerve, nerve root and plexus disorders

1.77

0.86

1.2

1.1

—

Lumbar disc prolapse

2.00

0.86

1.2

1.1

—

Hernia

1.81

0.85

1.0

1.1

—

Mood disorders, excluding more controls

1.81

0.83

1.1

—

Intracranial injury

1.89

0.82

1.2

1.1

—

Other cataract

0.00

0.80

0.0

1.1

—

Obesity due to excess calories

1.82

0.79

1.0

1.1

—

Other and unspecified disorders of vitreous body

0.00

0.79

0.0

1.0

—

Glaucoma

0.00

0.79

0.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.78

0.0

1.0

—

Other joint disorders

1.76

0.78

1.1

—

Angina pectoris

2.22

0.77

1.0

—

Major coronary heart disease event excluding revascularizations

2.22

0.77

1.2

1.0

—

Other functional intestinal disorders

0.00

0.76

0.0

1.0

—

Disorders of vitreous body

0.00

0.76

0.0

1.1

—

Metabolic disorders

1.74

0.76

1.1

—

Arthropathies

1.69

0.75

1.0

1.1

—

Zoster [herpes zoster]

2.14

0.75

1.0

1.1

—

Stroke, including SAH

2.13

0.75

1.2

1.0

—

Disorders of conjunctiva

1.68

0.75

1.1

—

Hypothyroidism, strict autoimmune

1.64

0.74

1.1

—

Irregular menses

1.84

0.73

1.1

—

Atopic dermatitis, strict definition

2.04

0.73

1.2

1.1

—

Chronic sinusitis

2.00

0.72

1.4

1.0

—

Dizziness and giddiness

1.79

0.72

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.76

0.71

1.1

—

Heart failure, not strict

1.76

0.71

1.1

—

Use of hypnotics and sedatives

1.66

0.71

1.0

1.1

—

Any gastric operation

1.73

0.71

1.1

—

GASTRO-related operations

1.73

0.71

1.1

—

Any reimbursement code in KELA

1.75

0.71

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.74

0.71

1.1

—

General symptoms and signs

1.67

0.70

1.0

1.1

—

Allergic conjunctivitis

1.70

0.69

1.1

—

Polycystic ovarian syndrome, consortium definition

1.69

0.69

1.1

—

Dental caries, including avohilmo

1.70

0.69

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.68

0.68

1.1

—

Atopic dermatitis, strict definition with reimbursement

1.86

0.68

1.2

1.1

—

Fracture of lower leg, including ankle

1.83

0.67

1.0

1.1

—

Depression

1.65

0.66

1.2

1.1

—

Urticaria and erythema

1.79

0.66

1.4

1.0

—

Hard cardiovascular diseases

1.70

0.64

1.1

1.0

—

Any mental disorder

1.62

0.64

1.0

1.1

—

Complications of medical and surgical care

1.57

0.64

1.0

1.1

—

Dermatitis and eczema

1.59

0.62

1.2

1.1

—

Other diseases of urinary system

1.58

0.61

1.1

—

Malignant neoplasm of digestive organs

0.00

0.61

0.0

1.0

—

Maternal care for other conditions predominantly related to pregnancy

0.00

0.60

0.0

1.0

—

Pre-eclampsia

0.00

0.60

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.60

0.0

1.0

—

Type of accident

0.00

0.60

0.0

1.0

—

Diseases of salivary glands

0.00

0.60

0.0

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.00

0.60

0.0

1.0

—

Exposure to unspecified factor

1.60

0.60

1.0

1.1

—

Insulin, fast-acting or short human

0.00

0.60

0.0

1.0

—

Insulin, fast-acting

0.00

0.60

0.0

1.0

—

Mycoses

1.55

0.59

1.0

1.1

—

Mouth breathing

0.00

0.59

0.0

1.0

—

Ischaemic heart disease, wide definition

1.77

0.59

1.2

1.0

—

Chronic apical periodontitis

1.57

0.59

1.2

1.1

—

Abnormalities of heart beat

0.00

0.59

0.0

1.1

—

Arthrosis

1.73

0.58

1.2

—

Medical treatment for female infertility

0.00

0.58

0.0

1.1

—

Triptan medication for migraine, single purchase ok

1.50

0.58

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.50

0.58

1.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.67

0.57

1.0

1.2

—

Hypertensive diseases (excluding secondary)

1.66

0.56

1.2

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.56

0.56

1.1

—

1.56

0.56

1.1

—

Injuries to the head

1.54

0.56

1.2

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.56

0.56

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.64

0.56

1.0

1.1

—

Acute sinusitis

1.63

0.56

1.0

1.1

—

Episodal and paroxysmal disorders

1.59

0.55

1.0

1.1

—

Psychiatric diseases

1.50

0.55

1.0

1.1

—

Chronic periodontitis, including avohilmo

1.51

0.55

1.1

—

Periodontitis

1.50

0.55

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.59

0.54

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

1.47

0.54

1.0

1.1

—

Cystitis

1.45

0.53

1.1

—

Benzodiazepine use

1.44

0.53

1.1

—

Complications of surgical and medical care, not elsewhere classified

1.43

0.52

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.52

0.52

1.3

1.0

—

Hypothyroidism, other/unspecified

1.41

0.51

1.1

—

Statin medication

1.64

0.51

1.0

1.1

—

Gonarthrosis,primary

1.54

0.49

1.0

1.1

—

Atopic dermatitis

1.55

0.49

1.3

1.1

—

Caries of dentine, including avohilmo

1.49

0.48

1.0

—

Injuries to the elbow and forearm

1.50

0.48

1.0

1.1

—

Gastro-oesophageal reflux disease

1.44

0.46

1.1

—

Selective serotonin reuptake inhibitors

1.49

0.44

1.0

1.1

—

Noninflammatory disorders of female genital tract

1.67

0.44

1.0

1.1

—

Gonarthrosis

1.68

0.44

1.0

1.1

—

Complications of procedures, not elsewhere classified

1.38

0.44

1.0

1.1

—

Other antidepressants

1.46

0.44

1.0

1.1

—

Chronic diseases of tonsils and adenoids

1.49

0.44

1.1

—

Abdominal and pelvic pain

1.44

0.43

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.43

0.43

1.0

1.1

—

Erysipelas

1.59

0.43

1.2

1.1

—

Other disorders of ear

1.42

0.42

1.3

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.58

0.42

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.41

0.42

1.1

—

Asthma-related infections

1.58

0.42

1.2

1.1

—

Asthma, hospital admission 2, infections

1.58

0.42

1.2

1.1

—

Dyspnoea

1.41

0.42

1.1

—

Other heart diseases

1.55

0.42

1.0

—

Fall on same level involving ice and snow

1.56

0.42

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.54

0.42

1.0

1.1

—

COPD related to multimorbidity

0.00

0.41

0.0

1.0

—

Actinic keratosis

0.00

0.41

0.0

1.1

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

0.41

0.0

1.1

—

Viral and other specified intestinal infections

0.00

0.41

0.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

0.00

0.41

0.0

1.1

—

Other and unspecified urticaria

0.00

0.41

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.41

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.41

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.41

0.0

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.41

0.0

1.0

—

Covid-19 suspected case

0.00

0.41

0.0

1.0

—

Benign paroxysmal vertigo

0.00

0.41

0.0

1.0

—

GI-bleeding

0.00

0.41

0.0

1.0

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.41

0.0

1.0

—

Type 1 diabetes, wide definition

0.00

0.41

0.0

1.0

—

Type 1 diabetes

0.00

0.41

0.0

1.0

—

0.00

0.40

0.0

1.1

—

Other diseases of the digestive system

0.00

0.40

0.0

1.0

—

Other diseases of anus and rectum

0.00

0.40

0.0

1.0

—

Genitourinary diseases

1.47

0.40

1.0

1.1

—

Pneumonia, organism unspecified

1.33

0.40

1.1

—

Diseases of the eye and adnexa

1.41

0.40

1.0

1.1

—

Degeneration of macula and posterior pole

0.00

0.40

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.40

0.0

1.1

—

Myalgia

0.00

0.40

0.0

1.0

—

Fracture at wrist and hand level

0.00

0.40

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

0.00

0.39

0.0

1.0

—

Diseases of the ear and mastoid process

1.42

0.39

1.1

—

Disorders of the thyroid gland

1.39

0.39

1.1

—

All kidney diseases

1.40

0.39

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.43

0.39

1.2

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.37

0.39

1.1

—

Nontoxic goitre/thyroid nodule

0.00

0.39

0.0

1.1

—

Glaucoma suspect

0.00

0.39

0.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.34

0.38

1.1

—

Persons encountering health services in other circumstances, wide

1.32

0.38

1.0

1.1

—

All pneumoniae

1.34

0.38

1.1

—

Any event in cancer register

1.32

0.38

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.39

0.38

1.0

1.1

—

Necrosis of pulp, including avohilmo

1.38

0.38

1.0

1.1

—

COPD/asthma related infections

1.43

0.38

1.0

1.1

—

COPD/asthma/ILD related infections

1.43

0.38

1.0

1.1

—

Other heart diseases, wide

1.31

0.37

1.0

1.1

—

Gastrointestinal diseases

1.50

0.37

1.0

1.1

—

Influenza and pneumonia

1.41

0.37

1.1

—

Other diseases of intestines

0.63

0.37

1.0

1.1

—

Other specific joint derangements/joint disorders

1.49

0.37

1.2

—

Conductive and sensorineural hearing loss

1.45

0.36

1.0

—

Obesity

1.45

0.35

1.0

1.1

—

Obesity and other hyperalimentation

1.41

0.35

1.0

1.1

—

Major coronary heart disease event

1.34

0.34

1.2

1.0

—

Other nutritional deficiencies

1.34

0.34

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.32

0.34

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.39

0.33

1.0

1.1

—

Artrosis, including avohilmo

1.37

0.32

1.0

1.1

—

Injuries to the shoulder and upper arm

1.38

0.31

1.0

1.1

—

Anxiety disorders, excluding more controls

1.34

0.31

1.0

1.1

—

Medical abortion

1.31

0.31

1.1

1.2

—

Pregnancy with abortive outcome

1.26

0.30

1.0

1.2

—

Abnormalities of breathing

1.29

0.28

1.1

—

Certain infectious and parasitic diseases

1.25

0.28

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

0.69

0.26

1.0

1.1

—

Autoimmune diseases

1.20

0.25

1.1

—

Diseases of the respiratory system

1.32

0.24

1.0

1.1

—

Sensorineural hearing loss

1.31

0.23

1.0

—

Persons encountering health services in circumstances related to reproduction

1.29

0.23

1.0

—

Anxiety (asthma-related co-morbidities)

1.29

0.23

1.0

1.1

—

Dermatophytosis

1.28

0.23

1.0

1.1

—

Other noninflammatory disorders of uterus, except cervix

0.00

0.22

0.0

1.0

—

Disorders of psychological development

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.1

—

Diverticular disease of intestine

1.18

0.21

1.0

1.1

—

Tooth eruption problems

0.00

0.21

0.0

1.1

—

Cardiac murmurs and other cardiac sounds

0.00

0.21

0.0

1.0

—

Other congenital malformations

0.00

0.21

0.0

1.0

—

Benign neoplasm of breast

0.00

0.21

0.0

1.0

—

Puerperal sepsis

0.00

0.21

0.0

1.0

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.21

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.21

0.0

1.0

—

Benign mammary dysplasia

0.00

0.21

0.0

1.0

—

Myopia

0.00

0.21

0.0

1.0

—

Crohn disease

0.00

0.21

0.0

1.0

—

Other disorders of conjunctiva

0.00

0.21

0.0

1.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.21

0.0

1.0

—

Enlarged lymph nodes

0.00

0.21

0.0

1.0

—

Retinal breaks without detachment

0.00

0.21

0.0

1.0

—

Azathioprine

0.00

0.21

0.0

1.0

—

ILD medications: azathioprine

0.00

0.21

0.0

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

0.21

0.0

1.0

—

Schizophrenia

0.00

0.21

0.0

1.0

—

Bacterial intestinal infections, IBD co-morbidities

0.00

0.21

0.0

1.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Other bacterial intestinal infections

0.00

0.21

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

0.21

0.0

1.0

—

DVT of lower extremities

0.00

0.21

0.0

1.0

—

Acute and subacute iridocyclitis

0.00

0.21

0.0

1.0

—

Other disorders of bone

0.00

0.21

0.0

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

1.0

—

Acute renal failure

0.00

0.21

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.0

—

Pacemaker

0.00

0.21

0.0

1.1

—

Implicit Sepsis

1.18

0.21

1.2

1.0

—

Otitis media, unspecified

0.00

0.21

0.0

1.1

—

Diabetic retinopathy, excluding more controls

0.00

0.21

0.0

1.1

—

Ulcerative colitis, NAS

0.00

0.21

0.0

1.0

—

Trigger finger

0.00

0.21

0.0

1.0

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.21

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.0

—

Somatoform disorder

0.00

0.21

0.0

1.0

—

Leisure time condition

0.00

0.21

0.0

1.0

—

Anterior Iridocyclitis

0.00

0.21

0.0

1.0

—

Other gastritis (incl. Duodenitis)

0.00

0.21

0.0

1.0

—

Primary open-angle glaucoma, strict

0.00

0.21

0.0

1.1

—

Presence of other devices

0.00

0.21

0.0

1.1

—

Ischemic heart diseases

1.29

0.21

1.2

1.0

—

Diabetic retinopathy

0.00

0.21

0.0

1.1

—

Neurological diseases

1.26

0.21

1.0

1.1

—

Adhesive capsulitis of shoulder

0.00

0.21

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.21

0.0

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.21

0.0

1.0

—

Nontoxic multinodular goitre

0.00

0.21

0.0

1.1

—

Acute appendicitis, with complications

0.00

0.21

0.0

1.0

—

Iridocyclitis

0.00

0.21

0.0

1.0

—

Impingement syndrome of shoulder

0.00

0.21

0.0

1.1

—

Effects of foreign body entering through natural orifice

0.00

0.21

0.0

1.0

—

Sulfonylureas

0.00

0.20

0.0

1.1

—

Impacted teeth

0.00

0.20

0.0

1.1

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.20

0.0

1.0

—

Injuries to the ankle and foot

1.27

0.20

1.2

1.1

—

Tonsillectomy and adenotomy

1.23

0.20

1.3

1.1

—

Inflammatory disease of uterus

0.00

0.20

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.20

0.0

1.0

—

Other diseases of blood and blood-forming organs, wide

0.00

0.20

0.0

1.0

—

5-aminosalicylic acid

0.00

0.20

0.0

1.0

—

Stomatitis and related lesions

0.00

0.20

0.0

1.0

—

Diagnoses used for exclusion with ILD

0.00

0.20

0.0

1.0

—

Seropositive rheumatoid arthritis

0.00

0.20

0.0

1.1

—

Retention of urine

0.00

0.20

0.0

1.0

—

Malignant neoplasm of breast, HER-negative

0.00

0.20

0.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.20

0.0

1.1

—

Primary open-angle glaucoma

0.00

0.20

0.0

1.1

—

Parasetamol

1.17

0.19

1.0

1.2

—

Exposure to other specified factors

1.20

0.19

1.0

1.1

—

Inflammatory diseases of female pelvic organs

1.16

0.19

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.72

0.17

1.4

1.1

—

Autoimmune diseases excluding thyroid diseases

0.72

0.17

1.4

1.1

—

Other diseases of upper respiratory tract

1.19

0.17

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.20

0.17

1.1

—

Type 2 diabetes, definitions combined

1.20

0.17

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.19

0.17

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.19

0.17

1.1

—

Type 2 diabetes

1.14

0.16

1.1

—

Diabetes medication

0.79

0.16

1.2

1.1

—

Persons encountering health services for specific procedures and health care

0.77

0.16

1.0

1.1

—

Persons encountering health services for examination and investigation

1.14

0.10

1.0

1.1

—

Percutaneous Coronary Intervention

1.13

0.10

1.2

1.0

—

Coronary revascularization (ANGIO or CABG)

1.13

0.10

1.2

1.0

—

Care involving use of rehabilitation procedures

1.12

0.10

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.09

0.10

1.2

1.1

—

Symptoms and signs involving the urinary system

1.09

0.09

1.2

1.1

—

All anxiety disorders

1.07

0.09

1.0

1.1

—

Hypertension, essential

1.06

0.09

1.2

1.1

—

Pain in throat and chest

1.03

0.08

1.0

1.1

—

Biguanides

0.78

0.08

1.2

1.1

—

Dental pulpitis, including avohilmo

1.11

0.08

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.09

0.08

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.07

0.08

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.09

0.08

1.0

1.1

—

Anxiety disorders

1.08

0.08

1.0

1.1

—

Soft tissue disorders

1.03

0.08

1.0

1.1

—

Used for control exclusion in common control thyroid runs

0.80

0.08

1.0

1.1

—

Other (not insulin) diabetes medications

0.85

0.08

1.2

1.1

—

Injuries to the wrist and hand

0.85

0.08

1.2

1.1

—

Diabetes, varying definitions

1.09

0.07

1.1

—

Diabetes mellitus

1.09

0.07

1.1

—

Intestinal infectious diseases

0.87

0.07

1.0

1.1

—

Redundant prepuce, phimosis and paraphimosis

0.00

0.0

1.0

—

Other and unspecified rosacea

0.00

0.0

1.0

—

Rosacea

0.00

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.0

1.0

—

Brachial plexus disorders

0.00

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.0

—

Dystonia

0.00

0.0

1.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Hypo-osmolality and hyponatraemia

0.00

0.0

1.0

—

Heterophoria

0.00

0.0

1.0

—

Other superficial mycoses

0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.2

—

Speech and linguistic disorders, excluding more controls

0.00

0.0

1.0

—

Agranulocytosis

0.00

0.0

1.0

—

Chondropathies

0.00

0.0

1.0

—

Budesonide

0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.0

1.0

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

1.0

—

Implicit fungal Sepsis

0.00

0.0

1.0

—

Postprocedural disorders of nervous system

0.00

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

0.0

1.0

—

Peripheral arterial reconstruction

0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

Other condition

0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Non-small cell lung cancer, including Hilmo

0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

0.0

1.3

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.0

—

Disorders of tooth development and eruption

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

0.0

1.0

—

Nail disorders

0.00

0.0

1.0

—

Malignant neoplasm of urinary organs

0.00

0.0

1.0

—

Nonspecific lymphadenitis

0.00

0.0

1.0

—

Adalimumab

0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

Other congenital malformations

0.00

0.0

1.0

—

Heartburn

0.00

0.0

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Insulin, fast-acting (human)

0.00

0.0

1.0

—

Symptoms and signs concerning food and fluid intake

0.00

0.0

1.0

—

Macular pucker

0.00

0.0

1.0

—

Gingival hyperplasia

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.0

—

Assault by bodily force

0.00

-0.00

0.0

1.0

—

Other respiratory diseases principally affecting the interstitium

0.00

-0.00

0.0

1.0

—

Use of memantine

0.00

-0.00

0.0

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bronchus and lung

0.00

-0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

1.2

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

-0.00

0.0

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.90

-0.00

1.2

1.1

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.0

—

Implicit Sepsis

0.99

-0.00

1.2

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.90

-0.00

1.2

1.1

—

Collagenous colitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm of mouth and pharynx

0.00

-0.00

0.0

1.0

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Ethmoidectomy

0.00

-0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Hypokalaemia

0.00

-0.00

0.0

1.0

—

Volume depletion

0.00

-0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.0

—

Other sleep disorders

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.0

—

FESS (DNB20)

0.00

-0.00

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Operations 2 for CAVS

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Intermittent heterotropia

0.00

-0.00

0.0

1.0

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.0

—

Other and unspecified visual disturbances

0.00

-0.00

0.0

1.0

—

Caries of enamel

0.96

-0.00

1.2

1.1

—

Acute pharyngitis

0.00

-0.00

0.0

1.1

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Ingrowing nail

0.00

-0.00

0.0

1.0

—

Diseases of the skin and subcutaneous tissue

0.91

-0.00

1.0

1.1

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

1.0

—

Ankylosing spondylitis, ICD10

0.00

-0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

-0.00

0.0

1.0

—

Other juvenile arthritis

0.00

-0.00

0.0

1.0

—

Other osteochondropathies

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

1.0

—

Abnormal weight loss

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Elevated blood glucose level

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

-0.00

0.0

1.0

—

Unspecified urinary incontinence

0.00

-0.00

0.0

1.0

—

Respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Foreign body on external eye

0.00

-0.00

0.0

1.0

—

Thiazolidinediones

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.0

—

Weight loss

0.00

-0.00

0.0

1.0

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.0

—

Desensitization to allergens

0.00

-0.00

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

-0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bordetella pertussis IgG Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS